A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
about
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescentsSelective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)Etiology of infantile autism: a review of recent advances in genetic and neurobiological research.Off-label indications for atypical antipsychotics: A systematic reviewNetworking in autism: leveraging genetic, biomarker and model system findings in the search for new treatmentsAutism spectrum disorders: early detection, intervention, education, and psychopharmacological managementLack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autismPharmacotherapy to control behavioral symptoms in children with autismAutism and serotonin transporter gene polymorphisms: a systematic review and meta-analysisThe serotonin system in autism spectrum disorder: From biomarker to animal modelsThe disruption of Celf6, a gene identified by translational profiling of serotonergic neurons, results in autism-related behaviors.Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.Functional neuroimaging of autistic disorders.Medication treatment in subjects with autistic spectrum disorders.Pharmacological management in children and adolescents with pervasive developmental disorder.Pharmacotherapy in children and adolescents with pervasive developmental disorders.Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder.Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report.Optogenetic insights on the relationship between anxiety-related behaviors and social deficits.A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.Personal reflections on observational and experimental research approaches to childhood psychopathology.The pathophysiology and treatment of autism.Treating the core features of autism: are we there yet?Prognosis in autism: do specialist treatments affect long-term outcome?Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism.Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.Medication strategies in childhood aggression: a review.Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder.A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children.Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder.AEDs and psychotropic drugs in children with autism and epilepsy.Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias.Assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatryThe minicolumnopathy of autism: A link between migraine and gastrointestinal symptoms.Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder.Pharmacotherapy for the core symptoms in autistic disorder: current status of the research
P2860
Q24200368-2EAE833B-7351-42A9-A0D7-A5EE7B2EEAACQ24201281-75285205-94F3-4149-B144-46E8B14B845CQ24236316-ACC166A8-1EA1-401E-9C6C-FA13DF90E379Q24535713-63008AF0-EA98-4A93-83CF-CAFA3F7140FFQ24803302-814B9D86-7D15-4260-B0D8-F70AB7098E8AQ26850307-12ABE727-E2B5-45E4-A990-6F7D3C7ABC1FQ28212094-1123058E-71C1-48F4-83E3-EB59EA37B75BQ28247116-AD7CB38B-8F5B-4C32-8201-793FC084C8D9Q28265801-FE30141D-5F46-4978-93F4-41278D15DB8DQ28269298-A7D4513C-3A84-4A4D-B0AF-12DCC317AE4EQ28391614-16796696-5C12-434C-8C21-36F6C741E5E4Q28508280-E74AF607-A58A-4CD9-B26C-A2AAACE47F47Q30482896-D6013792-C4E6-4F8E-844B-1DEED88B8261Q30607088-E3A354EF-BB04-4CE3-828D-F10F4973843DQ30612143-B4B85DA2-5B1D-45FD-A5EC-9ADDCA967DE6Q30623213-3562926A-F992-4610-96F2-7E50374E47F1Q33521748-08B80A8F-88EC-4BE0-97C6-1329EC584B0EQ33646475-666AA175-BBE5-4E96-8B5F-F81DAAA2D286Q33874461-F87E8059-36F5-46BF-B4E1-5107326C0296Q33891726-81FBE870-652B-4C3A-AED2-0220DD90EC9EQ33906973-F4E14A75-1516-4529-98B5-A52891AD802EQ33957170-B419D05B-E978-47C5-BC37-755B23AE7811Q34078071-7DF1DCB9-90A0-4371-A1FA-47FDCB21EBFAQ34200042-19E1EB7B-FF2A-4E8A-AE66-F06B7FCB76B6Q34387327-F4B3B985-0558-4D36-9C39-F4A756655840Q34435392-5F81B07D-F799-4A00-8812-B18A1C5A7B8BQ34470381-111F7787-BE2E-4F02-83F5-9D63F4C8F92FQ34706797-DFC03A5A-A490-49D0-B247-70ABEC0C08ABQ35151007-5E4783A4-5E80-461F-A8BC-1F468221971AQ35190427-E709DD39-DE87-4C05-85D7-03BEA03C05BFQ35250432-4B920111-26BA-44D5-97D1-04AC5740EF64Q35615132-0C9BFE89-3FEF-4A60-A881-DF6F553C1B56Q35851031-5121DD5F-66F7-4FFF-A21A-C6FC37FC5312Q35884885-C7C515A5-F6EB-4F89-839B-6CC4FA773B81Q35923595-92A285A7-91CE-4466-A600-5F2F078D79C3Q36168711-5947F229-5F1E-41CF-B9C7-8B05D91728F4Q36397920-8533E364-AC76-4B5D-8CA8-330183C5FE6CQ36443014-29C8D19D-3136-4D4E-B030-2220D708940CQ36700967-ABDC9E6E-C0A8-424A-BF4D-91BA13865F86Q36784208-625355D6-252A-4E92-A0D0-3663B5AC84C2
P2860
A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
A double-blind comparison of c ...... reatment of autistic disorder.
@en
A double-blind comparison of c ...... reatment of autistic disorder.
@nl
type
label
A double-blind comparison of c ...... reatment of autistic disorder.
@en
A double-blind comparison of c ...... reatment of autistic disorder.
@nl
prefLabel
A double-blind comparison of c ...... reatment of autistic disorder.
@en
A double-blind comparison of c ...... reatment of autistic disorder.
@nl
P2093
P1433
P1476
A double-blind comparison of c ...... reatment of autistic disorder.
@en
P2093
Hamburger SD
Rapoport JL
P304
P356
10.1001/ARCHPSYC.1993.01820180039004
P407
P577
1993-06-01T00:00:00Z